The information on this page has been prepared with reference to published scientific literature, not by a medically qualified expert. It is not medical advice. Any decision to use a supplement or herb-based product is your responsibility. Consult a suitably qualified medical professional, especially if you have underlying conditions. Remember, nothing is for everyone, and not everything sold is what it claims to be. Some things work for some people, some of the time.
It's important to clarify that forget-me-not (Myosotis) has very limited documented medicinal use in scientific literature. Despite its cultural significance and ornamental value, Myosotis species have not been extensively studied for therapeutic applications in modern clinical research.
The genus Myosotis belongs to the Boraginaceae family and contains approximately 75 species. Common names include forget-me-not, scorpion grass, and mouse ear. The most well-known species include Myosotis sylvatica (woodland forget-me-not), Myosotis arvensis (field forget-me-not), and Myosotis scorpioides (water forget-me-not).
Plants sometimes confused with forget-me-not include Chinese forget-me-not (Cynoglossum amabile) and Cape forget-me-not (Anchusa capensis), which are related Boraginaceae family members, but distinct genera with different potential properties.
There is a significant gap in peer-reviewed research regarding Myosotis species' medicinal properties. Unlike many other traditional herbs, forget-me-not has not been the subject of comprehensive clinical trials or systematic reviews. The plant contains pyrrolizidine alkaloids, which have raised safety concerns rather than demonstrated therapeutic benefits.
Historically, some traditional medicine systems have attributed minor medicinal properties to forget-me-not, including:
However, these traditional uses lack scientific validation through modern research methodologies.
Despite occasional claims in non-scientific sources, there is no reliable peer-reviewed evidence that forget-me-not treats or alleviates:
No scientifically established dosage guidelines exist for Myosotis species due to insufficient clinical research. The absence of standardization protocols for active compounds further complicates any dosage recommendations. Clinical trials establishing minimum effective doses or maximum tolerated doses have not been conducted.
Myosotis species contain pyrrolizidine alkaloids, compounds known to be potentially hepatotoxic (liver-damaging). These compounds have been associated with veno-occlusive disease and potential carcinogenicity in some Boraginaceae family members. No studies have systematically evaluated the toxicity profile or established safety thresholds for Myosotis consumption.
There are no FDA-approved or EMA-approved pharmaceutical products containing Myosotis extracts or compounds derived from forget-me-not species. The plant has not been developed into standardized pharmaceutical formulations due to limited evidence of therapeutic activity and safety concerns regarding pyrrolizidine alkaloid content.
The research literature on Myosotis species presents significant knowledge gaps including:
High-dose studies have not been conducted, as baseline efficacy has not been established in scientific literature.
Current scientific evidence does not support the use of forget-me-not (Myosotis species) for medicinal purposes. The plant lacks substantiated therapeutic benefits in peer-reviewed literature, while containing compounds with potential safety concerns. Individuals interested in herbal medicines should consult healthcare providers and rely on botanicals with established safety and efficacy profiles through clinical research.
Ebadi, M., Ghahraman, B., Matin, A. A., Mollaei, S., & Nikzat, S. (2023). Variation of phenolic acid compounds in the Iranian germplasm of Boraginaceae, a chemotaxonomy approach. Journal of Medicinal plants and By-Products, 13(1), 171-177.
Moreira, R., Pereira, D. M., Valentão, P., & Andrade, P. B. (2018). Pyrrolizidine alkaloids: chemistry, pharmacology, toxicology and food safety. International journal of molecular sciences, 19(6), 1668.
Stegelmeier, B. L., Edgar, J. A., Colegate, S. M., Gardner, D. R., Schoch, T. K., Coulombe, R. A., & Molyneux, R. J. (1999). Pyrrolizidine alkaloid plants, metabolism and toxicity. Journal of natural toxins, 8(1), 95-116.